Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 11—November 2009

Multicenter GeoSentinel Analysis of Rickettsial Diseases in International Travelers, 1996–2008

Mogens JenseniusComments to Author , Xiaohong Davis, Frank von Sonnenburg, Eli Schwartz, Jay S. Keystone, Karin Leder, Rogelio Lopéz-Véléz, Eric Caumes, Jakob P. Cramer, Lin Chen, Philippe Parola, and for the GeoSentinel Surveillance Network
Author affiliations: Oslo University Hospital, Oslo, Norway (M. Jensenius); University of Oslo, Oslo (M. Jensenius); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (X. Davis); University of Munich, Munich, Germany (F. von Sonnenburg); Chaim Sheba Medical Centre, Tel Hashomer, Israel (E. Schwartz); Toronto General Hospital, Toronto, Ontario, Canada (J.S. Keystone); Royal Melbourne Hospital, Parkville, Victoria, Australia (K. Leder); Ramón y Cajal Hospital, Madrid, Spain (R. Lopéz-Véléz); Hôpital Pitié-Salpêtrière, Paris, France (E. Caumes); Bernhard-Nocht-Clinic for Tropical Medicine, Hamburg, Germany (J.P. Cramer); Harvard Medical School, Boston, Massachusetts, USA (L. Chen); WHO Collaborative Center for Rickettsioses and Other Arthropod Borne Bacterial Diseases, Marseille, France (P. Parola); Hôpital Nord, Marseille (P. Parola); 1Additional members of the GeoSentinal Surveillance Network who contributed data are listed at the end of this article.

Main Article

Table 2

Univariate and multivariate analyses of risk factors associated with SFG rickettsiosis in travelers to sub-Saharan Africa, 1996–2008*

Variable Travelers with SFG rickettsiosis, N = 197† Travelers without SFG rickettsiosis, N = 11,690† Univariate association
Multivariate model‡
OR (95% CI) p value OR (95% CI) p value
Mean age, y 43.9, n = 196 36.5, n = 11,608 <0.0001 1.02 
(1.01–1.03)§ <0.0001
Male gender, no. (%) 115 (58.4), n = 197 6,105 (52.6), n = 11,599 1.26 
(0.95–1.68) 0.11 1.40 
(1.02–1.92) 0.035
Travel to southern Africa,¶ no. (%) 139 (70.6), n = 197 759 (6.5), n = 11,686 34.5 
(25.18–47.28) <0.0001 23.61 
(16.86–33.07) <0.0001
Travel in late summer,# no. (%) 89 (47.1), n = 189 4,220 (40.6), n = 10,402 1.30
(0.98–1.74) 0.07 1.57 
(1.15–2.15) 0.005
Travel duration >7 d, no. (%) 173 (91.5), n = 189 9,661 (92.9), n = 10,402 0.83
(0.49–1.39) 0.48 0.67 
(0.38–1.18) 0.164
No pretravel clinic visit, no. (%) 40 (21.7), n = 184 2,823 (26.5), n = 10,665 0.77 
(0.54–1.10) 0.15 0.98 
(0.66–1.44) 0.903
Independent travel,** no. (%) 34 (44.2), n = 77 4,100 (58.6), n = 6,993 0.56 
(0.35–0.87) 0.01 0.83 
(0.56–1.25) 0.373
Tourism as reason for travel, no. (%) 163 (82.7), n = 197 5,027 (43.0), n = 11,686 6.35 
(4.38–9.21) <0.0001 2.96 
(1.97–4.45) <0.0001

*SFG, spotted fever group; OR, odds ratio; CI, confidence interval.
†n = number of travelers for whom this information was available.
‡This model included all variables considered at univariate level because of their clinical relevance. The Hosmer and Lemeshow goodness-of-fit test for this model is p = 0.575.
§Odds ratio is for 1-y increase in age.
¶United Nations subregion comprising Botswana, Lesotho, Namibia, South Africa, and Swaziland.
**Independent travel was not formally collected by GeoSentinel until after May 2007.

Main Article

In addition to the authors, the following members of the GeoSentinel Surveillance Network contributed data: Kevin C. Kain, University of Toronto, Toronto, Ontario, Canada; Phyllis E. Kozarsky and Carlos Franco-Paredes, Emory University, Atlanta, Georgia, USA; Louis Loutan and François Chappuis, University of Geneva, Geneva, Switzerland; Joseph Torresi and Graham Brown, Royal Melbourne Hospital, Melbourne, Victoria, Australia; DeVon C. Hale and Stefanie S. Gelman, University of Utah, Salt Lake City, Utah, USA; Alice Pérignon, Hôpital Pitié-Salpêtrière, Paris, France; Gerd-Dieter Burchard, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany; Mary E. Wilson, Harvard University, Cambridge, Massachusetts, USA; Fabrice Simon and Jean Delmont, Hôpital Nord, Marseille, France; William M. Stauffer and Patricia F. Walker, University of Minnesota, Minneapolis, Minnesota, USA; Poh Lian Lim and Annelies Wilder-Smith, Tan Tock Seng Hospital, Singapore; Jose Antonio Perez Molina, Hospital Ramon y Cajal, Madrid, Spain; Bradley A. Connor, Cornell University, Ithaca, New York, USA; Carmelo Licitra and Antonio Crespo, Orlando Regional Health Center, Orlando, Florida, USA; David O. Freedman, University of Alabama at Birmingham, Birmingham, Alabama, USA; Effrossyni Gkrania-Klotsas, Addenbrooke's Hospital, Cambridge, UK; Giampiero Carosi and Francesco Castelli, University of Brescia, Brescia, Italy; Marc Shaw, Worldwise Travelers Health and Vaccination Centre, Auckland, New Zealand; Prativa Pandey, CIWEC Clinic Travel Medicine Center, Kathmandu, Nepal; R. Bradley Sack and Robin McKenzie, Johns Hopkins University, Baltimore, Maryland, USA (Dec 1997–Aug 2007); Elizabeth D. Barnett, Boston University, Boston, Massachusetts, USA; Christina M. Coyle and Murray Wittner, Albert Einstein School of Medicine, Bronx, New York, USA; Stefan Hagmann and Andy Miller, Bronx-Lebanon Hospital Center, Bronx; Michael W. Lynch, Fresno International Travel Medical Center, Fresno, California, USA; Vanessa Field, InterHealth, London, UK; Michael D. Libman and J. Dick Maclean, McGill University, Montreal, Quebec, Canada; Alejandra Gurtman, Mount Sinai Medical Center, New York, New York, USA (Oct 2002–Aug 2005); Shuzo Kanagawa and Yasuyuki Kato, International Medical Center of Japan, Tokyo, Japan; and Patricia Schlagenhauf, Rainer Weber, and Robert Steffen, University of Zürich, Zürich, Switzerland.

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.